GLP-1 receptor agonists (such as semaglutide and tirzepatide) are FDA-approved for Type 2 diabetes and chronic weight management
Is GLP-1 a good natural alternative to weight loss drugs
The onset of one condition can increase the risk of the other, potentially creating a self-reinforcing cycle of disease progression [39, 40]
These findings are exciting because they suggest GLP-1 receptor agonists could have broader kidney-protective effects than initially thought, said the papers first author, Jefferson Triozzi, MD, MSCI, instructor in Medicine in the Division of Nephrology and Hypertension at VUMC
Brand-name medications like Ozempic ($1,498/month without insurance) and Zepbound ($1,828/month without insurance) are also available